SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-054278
Filing Date
2023-11-02
Accepted
2023-11-02 21:40:05
Documents
2
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10571
2 POA DOCUMENT poa.txt EX-24 3373
  Complete submission text file 0001209191-23-054278.txt   17641
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address
Stampacchia Otello (Reporting) CIK: 0001361712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374330

Mailing Address C/O OMEGA FUND MANAGEMENT, LLC 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address
Paster Anne-Mari (Reporting) CIK: 0001652863 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374328

Mailing Address C/O NEOMED 7 PLACE DU MOLARD 1204 GENEVA V8 1204
Business Address
Nessi Claudio (Reporting) CIK: 0001722050 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374329

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund VI, L.P. (Reporting) CIK: 0001757917 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374333

Mailing Address 888 BOYLSTON STREET, SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON STREET, SUITE 1111 BOSTON MA 02199 617-502-6530
Omega Fund VI GP Manager, Ltd. (Reporting) CIK: 0001826584 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374331

Mailing Address 888 BOYLSTON STREET, SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON STREET, SUITE 1111 BOSTON MA 02199 617-502-6530
Omega Fund VI GP, L.P. (Reporting) CIK: 0001826592 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374332

Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)